Navigation Links
Ameritox® Continues to Advance Industry Leadership
Date:2/4/2011

rshipAmeritox secured licensing rights from Marshfield Clinic to continue developing a new technology to assist in determining the likelihood of patient adherence. Ameritox will further develop this technology for commercialization and support additional research and development, greatly expanding the scope and usability of pain medication monitoring among its physician partners.

Team Ameritox:Adding to considerable bench strength within the company, the Ameritox team has grown significantly to enhance support for the company's physician partners across the nation.

As a further benefit to both the physician service and  leading Medical Science Liaison team for which it is known, Ameritox has appointed Kathryn S. Bronstein, PhD, RN, as Director of Medical Science and Health Outcomes, and expanded its Medical Science Liaison team with the additions of David E. Chapman, PhD; Monica A. Fay, PharmD., MBA; Lisa M. Burke, PhD, MBA, RN; and Barry Cohen, PhD as Assistant Directors of Medical Science and Health Outcomes Research.  Kendra L. Davies, B.S., PharmD, also joined as Associate Director, Medical Affairs, rounding out a team focused on maintaining the highest level of clinical and research rigor in the industry.  

The company has also formed a new Government Programs department to expand support to public health care providers who manage patients on chronic opioid therapy.

About Ameritox Ameritox is the nation's leader in pain medication monitoring solutions, offering specialized laboratory testing and reporting services. Ameritox's expertise and innovative science provides physicians with insights and support to enhance and optimize the care of chronic pain patients. Ameritox offers Rx Guardian(SM), the most thorough and personalized lab service available and the only pain medication testing program with a proprietary methodology to help physicians assess whether patients are taking their pain medication as directed.
'/>"/>

SOURCE Ameritox
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Adult Smoking Rate Continues Downward Trend
2. Gilbert Hospital Continues Cutting Edge Treatments
3. The OrthoGlide(TM) Medial Knee Implant Continues to be Accepted as an Alternative to Total Knee Replacement
4. Bone Mineral Content Continues to Increase in Obese Adolescents During Weight Loss
5. Phase I and Phase I/II DCVax(R)-Brain Data Continues to Show Significantly Improved Survival Rates for Brain Cancer Patients
6. Nuvelo Announces Phase 2 SONOMA-3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development
7. Carpet One Floor & Home Continues Making Dramatic Strides in Funding Breast Cancer Research and Awareness
8. Medarex Announces Ipilimumab Program Continues to Move Forward
9. Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months
10. Replidyne Discontinues Phase III Trial
11. AlphaVax Continues to Expand the Use of Its Vaccine Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 24, 2014 /CNW/ -   ... after Health Canada tests confirmed it contains two undeclared ... and phenylpropylmethylamine). The distributor, Empire Health Distribution of ... from retail stores across Canada . ... for weight loss and increased energy. ...
(Date:12/24/2014)... Mexico , Dec. 24, 2014  Novastem, ... of its first patient in its study for ... the American Stroke Association, ischemic strokes account for ... to enroll qualified patients in the study, entitled ... Administration of Allogeneic Mesenchymal Stem Cells and Intrathecal ...
(Date:12/24/2014)... , Dec. 24, 2014  Actavis plc (NYSE: ... Company has received a complete response letter from ... its New Drug Application (NDA) for the fixed-dose ... treatment of hypertension.   Photo - ... disappointed in the receipt of a complete response ...
Breaking Medicine Technology:"Jetfuel Superburn" recalled after Health Canada tests find undeclared drug ingredients 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 3Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 4Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 2Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 3Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 4
(Date:12/25/2014)... 2014 Parker & Sons, Inc. an ... and affordable quality regarding heating, cooling and plumbing services ... 2014 by the “Queen of Clean” for impressive contractor ... impressive reputation over the years for providing outstanding quality ... of contractor services for both homeowners and businesses. Linda ...
(Date:12/24/2014)... 25, 2014 AlignLife of Wauwatosa ... afford certain items. During the holiday season, AlignLife looks forward ... 70 toys," says Dr. Sara Mahalko-Leonhardt, owner of AlignLife. "It ... joy, knowing that we are able to give kids toys ... not been for the generosity of our patients." , The ...
(Date:12/24/2014)... Over 700 toys, that’s what AlignLife clinics ... smiling little faces this holiday that might not have ... donations was given to the various charities as well ... through the year. Some of the charities chosen for ... Shrine's Children's Hospitals, Toys for Tots and Crisis Nurseries, ...
(Date:12/24/2014)... Epigenetics finds applications in a large number of fields ... biology, and research for metabolic and genetic disorders. It ... used techniques for the discovery and development of cancer ... rapidly growing worldwide. In 2012, there were 14.1 million ... million people living with cancer (within five years of ...
(Date:12/24/2014)... 2014 Connie Casad, MD, a well-known ... advocate with 30 years of practice experience in Dallas, ... health benefits of dietary detoxification. The second study is ... excellent results from test patients who just completed a ... her interest in conducting the study, Dr. Casad said, ...
Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Recognition In 2014 By The “Queen Of Clean” For Impressive Contractor Services In Arizona 2Health News:Parker & Sons Announces Recognition In 2014 By The “Queen Of Clean” For Impressive Contractor Services In Arizona 3Health News:AlignLife of Wauwatosa Brings Joy to Less Fortunate Families 2Health News:AlignLife Donates Over 700 Toys This Year 2Health News:Global Epigenetics Market Was Valued at $413.24 Million in 2014 - New Research Report by MarketsandMarkets 2Health News:Global Epigenetics Market Was Valued at $413.24 Million in 2014 - New Research Report by MarketsandMarkets 3Health News:Connie Casad, MD, Now Accepting Test Participants for January Dietary Detoxification Study 2Health News:Connie Casad, MD, Now Accepting Test Participants for January Dietary Detoxification Study 3
... business response to global economic and social challengesNEW YORK, April ... aimed at creating new partnerships with governments, NGOs and small ... on Creating Shared Value in New York ... and the Mission of ...
... Inc. (OTC Bulletin Board: PLCSF) announced today that it expects ... the first quarter ended March 31, 2009 before the market ... host a conference call to discuss those results at 11:00 ... joined via telephone by dialing (866) 825-1708 or (617) 213-8060 ...
... 27 Cornerstone Therapeutics Inc. (NasdaqCM: CRTX), a specialty ... for respiratory disorders, today announced that it will host ... May 7, 2009, to discuss its financial results for ... also provide an update on the Company,s strategy, operations ...
... TERI, Inc., a national leader ... with autism and other developmental disabilities, today announced ... Quality Plans(TM) for families and caregivers of people ... the TERI-led International Association for Life Quality ( ...
... Group at Frost & Sullivan is pleased ... the Pharmaceutical CRM Market to be held on Tuesday, ... http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO )2008 has ushered in a variety of ... is adopting a cautious approach, delaying and re-evaluating technology ...
... to highlight advances for chronic condition; third FDA-approved drug to come ... ... Each new treatment that becomes available is a step forward for ... National Fibromyalgia Association (NFA), which is observing Fibromyalgia Awareness ...
Cached Medicine News:Health News:Nestle Launches Major Initiatives in Nutrition, Water and Rural Development 2Health News:Nestle Launches Major Initiatives in Nutrition, Water and Rural Development 3Health News:Nestle Launches Major Initiatives in Nutrition, Water and Rural Development 4Health News:Cornerstone Therapeutics to Host First Quarter 2009 Conference Call 2Health News:Cornerstone Therapeutics to Host First Quarter 2009 Conference Call 3Health News:Cornerstone Therapeutics to Host First Quarter 2009 Conference Call 4Health News:TERI Offers Comprehensive Life Quality Plans to Families, Caregivers of People with Developmental Disabilities 2Health News:Frost & Sullivan: The Pharmaceutical Customer Relationship Management Market - What are the Emerging Trends and Opportunities? 2Health News:Frost & Sullivan: The Pharmaceutical Customer Relationship Management Market - What are the Emerging Trends and Opportunities? 3Health News:Treatment Options Increase For Millions with Fibromyalgia 2Health News:Treatment Options Increase For Millions with Fibromyalgia 3
... are problem enough for your patients. Now you ... functional treatment for foot and ankle fractures and ... A combination of prefabricated brace and open foam ... higher standards of safety. The storm can be ...
... Walker Pediatric Boot is the ... boot that offers superior comfort ... two sizes are offered thus ... will fit left or right, ...
... Bledsoe Mid-Calf Boot is a shorter ... boot designed for second degree ankle ... incision protection. The Bledsoe EZ Set ... of motion from 20 degrees of ...
... The Bledsoe Conformer Diabetic Boot features ... cocoon attached to a unique auto-molding innersole ... mid-sole insert in an aluminum shelled walking ... is designed to evenly distribute body weight ...
Medicine Products: